282 related articles for article (PubMed ID: 35378273)
1. Chemokines driven ovarian cancer progression, metastasis and chemoresistance: Potential pharmacological targets for cancer therapy.
Bose S; Saha P; Chatterjee B; Srivastava AK
Semin Cancer Biol; 2022 Nov; 86(Pt 2):568-579. PubMed ID: 35378273
[TBL] [Abstract][Full Text] [Related]
2. Cytokine-chemokine network driven metastasis in esophageal cancer; promising avenue for targeted therapy.
Bhat AA; Nisar S; Maacha S; Carneiro-Lobo TC; Akhtar S; Siveen KS; Wani NA; Rizwan A; Bagga P; Singh M; Reddy R; Uddin S; Grivel JC; Chand G; Frenneaux MP; Siddiqi MA; Bedognetti D; El-Rifai W; Macha MA; Haris M
Mol Cancer; 2021 Jan; 20(1):2. PubMed ID: 33390169
[TBL] [Abstract][Full Text] [Related]
3. Research progress on anti-ovarian cancer mechanism of miRNA regulating tumor microenvironment.
Cui M; Liu Y; Cheng L; Li T; Deng Y; Liu D
Front Immunol; 2022; 13():1050917. PubMed ID: 36439168
[TBL] [Abstract][Full Text] [Related]
4. Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion.
Tian W; Lei N; Zhou J; Chen M; Guo R; Qin B; Li Y; Chang L
Cell Death Dis; 2022 Jan; 13(1):64. PubMed ID: 35042862
[TBL] [Abstract][Full Text] [Related]
5. LncRNA MALAT1 Facilitates Ovarian Cancer Progression through Promoting Chemoresistance and Invasiveness in the Tumor Microenvironment.
Mao TL; Fan MH; Dlamini N; Liu CL
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638541
[TBL] [Abstract][Full Text] [Related]
6. Tumor microenvironment signaling and therapeutics in cancer progression.
Goenka A; Khan F; Verma B; Sinha P; Dmello CC; Jogalekar MP; Gangadaran P; Ahn BC
Cancer Commun (Lond); 2023 May; 43(5):525-561. PubMed ID: 37005490
[TBL] [Abstract][Full Text] [Related]
7. Conditioning solid tumor microenvironment through inflammatory chemokines and S100 family proteins.
Nasser MW; Elbaz M; Ahirwar DK; Ganju RK
Cancer Lett; 2015 Aug; 365(1):11-22. PubMed ID: 25963887
[TBL] [Abstract][Full Text] [Related]
8. The Role of Tumor-Associated Macrophages in the Progression and Chemoresistance of Ovarian Cancer.
Nowak M; Klink M
Cells; 2020 May; 9(5):. PubMed ID: 32456078
[TBL] [Abstract][Full Text] [Related]
9. Targeting the tumour microenvironment in platinum-resistant ovarian cancer.
Cummings M; Freer C; Orsi NM
Semin Cancer Biol; 2021 Dec; 77():3-28. PubMed ID: 33607246
[TBL] [Abstract][Full Text] [Related]
10. Tumour microenvironment and metabolic plasticity in cancer and cancer stem cells: Perspectives on metabolic and immune regulatory signatures in chemoresistant ovarian cancer stem cells.
Ahmed N; Escalona R; Leung D; Chan E; Kannourakis G
Semin Cancer Biol; 2018 Dec; 53():265-281. PubMed ID: 30317036
[TBL] [Abstract][Full Text] [Related]
11. The clinical impact of intra- and extracellular miRNAs in ovarian cancer.
Yoshida K; Yokoi A; Kato T; Ochiya T; Yamamoto Y
Cancer Sci; 2020 Oct; 111(10):3435-3444. PubMed ID: 32750177
[TBL] [Abstract][Full Text] [Related]
12. Role of Extracellular Vesicles in Epithelial Ovarian Cancer: A Systematic Review.
Lucidi A; Buca D; Ronsini C; Tinari S; Bologna G; Buca D; Leombroni M; Liberati M; D'Antonio F; Scambia G; Lanuti P; Petrillo M
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33228245
[TBL] [Abstract][Full Text] [Related]
13. Chemokines and Their Receptors: Predictors of Therapeutic Potential in Tumor Microenvironment on Esophageal Cancer.
Huang CG; Liu Q; Zheng ST; Liu T; Tan YY; Peng TY; Chen J; Lu XM
Dig Dis Sci; 2024 May; 69(5):1562-1570. PubMed ID: 38580886
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms and Therapeutic Targets of microRNA-associated Chemoresistance in Epithelial Ovarian Cancer.
Zhang L; Nadeem L; Connor K; Xu G
Curr Cancer Drug Targets; 2016; 16(5):429-41. PubMed ID: 27040353
[TBL] [Abstract][Full Text] [Related]
15. NSAID-activated gene 1 mediates pro-inflammatory signaling activation and paclitaxel chemoresistance in type I human epithelial ovarian cancer stem-like cells.
Kim KH; Park SH; Do KH; Kim J; Choi KU; Moon Y
Oncotarget; 2016 Nov; 7(44):72148-72166. PubMed ID: 27708225
[TBL] [Abstract][Full Text] [Related]
16. Cytokine- and chemokine-induced inflammatory colorectal tumor microenvironment: Emerging avenue for targeted therapy.
Bhat AA; Nisar S; Singh M; Ashraf B; Masoodi T; Prasad CP; Sharma A; Maacha S; Karedath T; Hashem S; Yasin SB; Bagga P; Reddy R; Frennaux MP; Uddin S; Dhawan P; Haris M; Macha MA
Cancer Commun (Lond); 2022 Aug; 42(8):689-715. PubMed ID: 35791509
[TBL] [Abstract][Full Text] [Related]
17. S100A7 Regulates Ovarian Cancer Cell Metastasis and Chemoresistance Through MAPK Signaling and Is Targeted by miR-330-5p.
Lin M; Xia B; Qin L; Chen H; Lou G
DNA Cell Biol; 2018 May; 37(5):491-500. PubMed ID: 29485916
[TBL] [Abstract][Full Text] [Related]
18. Chemokines and receptors in the development and progression of malignant tumors.
Zhao HQ; Jiang J
Cytokine; 2023 Oct; 170():156335. PubMed ID: 37591136
[TBL] [Abstract][Full Text] [Related]
19. Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer.
Kanlikilicer P; Bayraktar R; Denizli M; Rashed MH; Ivan C; Aslan B; Mitra R; Karagoz K; Bayraktar E; Zhang X; Rodriguez-Aguayo C; El-Arabey AA; Kahraman N; Baydogan S; Ozkayar O; Gatza ML; Ozpolat B; Calin GA; Sood AK; Lopez-Berestein G
EBioMedicine; 2018 Dec; 38():100-112. PubMed ID: 30487062
[TBL] [Abstract][Full Text] [Related]
20. Targeting tumor microenvironment in ovarian cancer: Premise and promise.
Jiang Y; Wang C; Zhou S
Biochim Biophys Acta Rev Cancer; 2020 Apr; 1873(2):188361. PubMed ID: 32234508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]